1163707-73-0 Usage
Description
5-Bromo-N-tert-butyl-2-nitroaniline is a chemical compound characterized by its molecular formula C10H13BrN2O2. It presents as a yellow to brown crystalline solid, which is insoluble in water but readily soluble in organic solvents. 5-Bromo-N-tert-butyl-2-nitroaniline is recognized for its role as an intermediate in the synthesis of pharmaceuticals and agrochemicals, as well as in the production of dyes and pigments.
Uses
Used in Pharmaceutical and Agrochemical Industries:
5-Bromo-N-tert-butyl-2-nitroaniline is utilized as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique chemical structure allows it to be a valuable component in the development of new drugs and agricultural products, contributing to the advancement of these fields.
Used in Dye and Pigment Production:
In the dye and pigment industry, 5-Bromo-N-tert-butyl-2-nitroaniline is employed for its color-producing properties. Its ability to create distinct hues makes it a useful ingredient in the formulation of dyes and pigments for a variety of applications, including textiles, plastics, and printing inks.
Safety Considerations:
5-Bromo-N-tert-butyl-2-nitroaniline is classified as a hazardous substance. It is important to handle this compound with care to avoid potential irritation to the skin, eyes, and respiratory system. Proper safety measures and protective equipment should be used during its production, storage, and use to minimize health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 1163707-73-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,3,7,0 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1163707-73:
(9*1)+(8*1)+(7*6)+(6*3)+(5*7)+(4*0)+(3*7)+(2*7)+(1*3)=150
150 % 10 = 0
So 1163707-73-0 is a valid CAS Registry Number.
1163707-73-0Relevant articles and documents
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
-
Paragraph 0274, (2021/03/05)
Provided herein are compounds, preferably thyroid hormone receptor beta (THR beta) agonist compounds, compositions thereof, and methods of their preparation, and methods of agonizing THR beta and methods for treating disorders mediated by THR beta.
ORGANIC COMPOUNDS
-
Page/Page column 67-68, (2010/04/06)
The present invention relates to a compound of formula (I) (I) or a salt thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.
